Skip to main content

Table 1 Results from the Real World Feasibility Study [32].

From: Will availability of inhaled human insulin (Exubera®) improve management of type 2 diabetes? The design of the Real World trial

Current treatment

Percentage of study patients (%)

Treatment preferences (%)

   

"I will NOT change my current treatment"

"I am willing to consider new oral agents"

"I am willing to consider SC insulin"

"I am willing to consider inhaled insulin"

 

Inhaled insulin available

Inhaled insulin NOT available

Inhaled insulin available

Inhaled human insulin NOT available

Inhaled insulin available

Inhaled insulin NOT available

Inhaled insulin available

Inhaled insulin NOT available

Inhaled insulin available

Inhaled insulin NOT available

Diet/exercise

5.4

7.2

28.6

39.3

47.6

60.7

4.8

0

4.8

N/A

1 oral agent

32.5

36.6

26.0

41.5

33.9

43.0

5.5

14.1

30.7

N/A

2 oral agents

52.4

46.1

28.8

45.3

19.0

35.8

8.3

17.9

38.5

N/A

3 oral agents

9.7

10.1

23.7

43.6

5.3

33.3

15.3

20.5

50.0

N/A